|
Pharmacy Information 2024
续断及其配方颗粒的UPLC指纹图谱研究
|
Abstract:
目的:建立续断药材及配方颗粒的UPLC指纹图谱,为续断配方颗粒质量控制提供有效方法。方法:采用UPLC同时测定10批续断药材和10批配方颗粒,制定指纹图谱。色谱柱为Agilent ZORBAX Eclipse Plus C18 (2.1 mm × 100 mm, 1.8 μm);流速0.2 mL·min?1;检测波长212 nm;柱温30℃;进样量1 μL;流动相:0.1%磷酸水(A)-乙腈(C)二元梯度洗脱。结果:10批续断药材有25个共有色谱峰,10批续断配方颗粒有32个共有色谱峰,10批续断药材与10批配方颗粒确定25个共有峰,各峰之间分离度较高。10批续断药材和10批配方颗粒的相似度均大于0.8,10批配方颗粒的相似度大于0.9。结论:建立的续断药材和配方颗粒指纹图谱稳定可靠,药材与配方颗粒的色谱峰个数有较大的差异,说明药材经提取、浓缩、制粒等制备工艺后,化学成分有所变化,存在差异。
Objective: To establish the UPLC fingerprints of Dipsacus asper W. and formulated granules, and to provide an effective method for the quality control of the formulated granules of Dipsacus asper W. Methods: UPLC was used to simultaneously determine 10 batches of Dipsacus asper W. and 10 batches of the formulated granules of Dipsacus asper W. and to develop the fingerprint profiles. The chromatographic column was Agilent ZORBAX Eclipse plus C18 (2.1 mm × 100 mm, 1.8 μm); the flow rate was 0.2 mL?min?1; the detection wavelength was 212 nm; the column temperature was 30?C; the injection volume was 1 μL; and the mobile phase was a binary gradient elution of 0.1% phosphoric acid in water (A)-acetonitrile (C). Result: There were 25 common chromatographic peaks in 10 batches of Dipsacus asper W., 32 common chromatographic peaks in 10 batches of Formula granules, and 25 common peaks were determined between 10 batches of Dipsacus asper W. and 10 batches of formula particles, with high separation between each peak. The similarity between 10 batches of Dipsacus asper W. and 10 batches of formula particles is greater than 0.8, and the similarity between 10 batches of formula particles is greater than 0.9. Conclusion: The fingerprints of Dipsacus asper W. and Formula granules were stable and reliable and the number of chromatographic peaks of the herbs and the formulated particles had a large difference, indicating that the chemical compositions of the herbs had changed and differed after the preparation process of extraction, concentration and granulation.
[1] | 张成刚, 杨昌贵, 肖承鸿, 等. 中药续断的化学成分研究[J]. 山东科学, 2022, 35(5): 1-9. |
[2] | 刘丽, 杨征, 傅若秋, 等. 续断化学成分、药理作用及炮制对其质量的影响研究进展[J]. 中国药业, 2023, 32(13): 126-133. |
[3] | 黄蒙蒙, 周广涛, 张霞, 等. 续断化学成分及药理作用研究进展[J]. 药学研究, 2023, 42(10): 837-840. |
[4] | 刘丽娟, 苏丹, 李婉慧, 等. 川续断皂苷乙通过调节细胞免疫平衡对哮喘小鼠气道炎症的减轻作用[J]. 医学研究与战创伤救治, 2023, 36(11): 1127-1134. |
[5] | 金芳全, 樊成虎, 唐晓栋, 等. 续断提取物对骨质疏松性大鼠信号通路作用的研究进展[J]. 中国骨质疏松杂志, 2023, 29(7): 1016-1020. |
[6] | 崔金帅, 刘妍, 王子颖, 等. 续断及其有效成分的抗痴呆作用及研究进展[J]. 药学学报, 2022, 57(10): 3057-3066. |
[7] | 黄荣. 中药配方颗粒发展与研究现状[J]. 中医药管理杂志, 2024, 32(5): 82-84. |
[8] | 汤甜甜. 基层医院中药代煎常见问题分析与对策[J]. 中国乡村医药, 2024, 31(8): 42-43. |
[9] | 陈文斌. 阻碍中药配方颗粒发展的问题分析[J]. 内蒙古中医药, 2023, 42(10): 122-123. |
[10] | 郭煦. 中药配方颗粒的现代化之路[J]. 小康, 2023(10): 34-37. |
[11] | 冯英姿, 郑路亚. 从治疗效果的角度分析中药免煎颗粒优劣[J]. 中医药管理杂志, 2022, 30(22): 153-155. |
[12] | 范晓燕. 从中药传承角度探讨中药饮片和中药配方颗粒的应用[J]. 中医药管理杂志, 2022, 30(19): 131-133. |
[13] | 李高岩, 杨一荻, 曲范娜, 等. 中药配方颗粒研究现状及问题思考[J]. 药学研究, 2024, 43(1): 99-104. |
[14] | 岳佑凇, 张璐, 王艳丽, 等. 中药配方颗粒汤剂与传统汤剂对比研究进展与有关问题分析[J]. 医药导报, 2023, 42(7): 1033-1038. |
[15] | 朱佩佩, 杨洪军, 李耿, 等. 中药配方颗粒产业与监管的思考[J/OL]. 中国中药杂志: 1-15. https://doi.org/10.19540/j.cnki.cjcmm.20240415.304, 2024-04-29. |
[16] | 孟祥云, 汪远, 胡泊, 等. 中药饮片煎煮制剂质控现状及对策研究[J]. 中国当代医药, 2022, 29(17): 142-145, 149. |
[17] | 符海郯, 张倩睿, 吴方建. 现代分析技术用于中药质量控制研究进展[J]. 中国药业, 2019, 28(22): 96-99. |
[18] | 刘静, 亓超凡, 绪扩, 等. 指纹图谱技术在食品质量与安全中的应用研究进展[J]. 食品安全质量检测学报, 2022, 13(10): 3189-3197. |
[19] | 陈彤彤, 于猛, 李凤霞, 等. 芦荟药材化学成分鉴定及UPLC指纹图谱分析[J]. 中草药, 2022, 53(8): 2470-2479. |
[20] | 黄洁. 中药颗粒剂的优势与应用前景[J]. 中国社区医师, 2023, 39(9): 4-6. |
[21] | 叶嘉凌, 罗健麟. 中药房调配的免煎中药配方颗粒处方的合理性分析[J]. 临床合理用药杂志, 2022, 15(16): 162-164, 170. |